Metadata
Author: EurLex-2
Data
Bulgarian[bg]
Според Greenwood (Greenwood, „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying“, в Pedler, van Schendelen (Hrsg.), Issues and Cases In European Public Affairs, 1994, стр. 183 и сл., стр. 188) до 1984—1985 г. се е обсъждало изработването на европейска директива за определяне на цените на лекарствените продукти.
Czech[cs]
Podle Greenwood [Greenwood, „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying“, in: Pedler/van Schendelen (vydavatel), Issues and Cases In European Public Affairs, 1994, s. 183 a násl., s. 188] se až do roku 1984/1985 diskutovalo o vypracování evropské směrnice o tvorbě cen léčivých přípravků.
Danish[da]
Ifølge Greenwood (Greenwood, »Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying«, i: Pedler og van Schendelen [red.], Issues and Cases In European Public Affairs, 1994, s. 183 ff., s. 188) blev det indtil 1984/85 drøftet, om der skulle udarbejdes et fællesskabsretligt direktiv om prisfastsættelse for lægemidler.
German[de]
Laut Greenwood (Greenwood, „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying“, in: Pedler/van Schendelen [Hrsg.], Issues and Cases in European Public Affairs, 1994, S. 183 ff., S. 188) stand bis 1984/85 zur Diskussion, eine europäische Arzneimittelpreisfestsetzungsrichtlinie zu erarbeiten.
Greek[el]
Κατά τον Greenwood (Greenwood, «Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying», σε Pedler/van Schendelen [εκδότης], IssuesandCasesInEuropeanPublicAffairs, 1994, σ. 183 επ., σ. 188) μέχρι το 1984/1985 συζητείτο το ζήτημα της εκδόσεως μιας κοινοτικής οδηγίας για τον καθορισμό των τιμών των φαρμάκων.
English[en]
According to Greenwood (‘Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying’, in: Pedler and van Schendelen [publ.], Issues and Cases In European Public Affairs, 1994, p. 183 et seq., p. 188), the question of drawing up a European pharmaceuticals pricing directive was under discussion until 1984/1985.
Spanish[es]
Según Greenwood (Greenwood, «Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying», en: Pedler/van Schendelen [Hrsg.], Issues and Cases in European Public Affairs, 1994, pp. 183 y ss., especialmente p. 188), hasta 1984/85 se discutió la posibilidad de elaborar una Directiva europea de fijación de precios de los medicamentos.
Estonian[et]
Greenwoodi sõnul (Greenwood, „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, teoses Pedler ja van Schendelen, Issues and Cases In European Public Affairs, 1994, lk 183 jj, lk 188) arutati kuni 1984. ja 1985. aastani ravimite hinnakujunduse Euroopa direktiivi koostamist.
Finnish[fi]
Greenwoodin mukaan (Greenwood, ”Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, teoksessa Pedler ja van Schendelen (toim.), Issues and Cases In European Public Affairs, 1994, s. 183 ja sitä seuraavat sivut, s. 188) vuosina 1984–1985 keskusteltiin lääkkeiden hintojen vahvistamista koskevan EU-direktiivin laatimisesta.
French[fr]
Selon Greenwood («Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying», in: Pedler/van Schendelen [éd.], Issues and Cases In European Public Affairs, 1994, p. 188), jusqu’en 1984/1985 la préparation d’une directive européenne concernant la fixation du prix des médicaments a été discutée.
Hungarian[hu]
Greenwood szerint (Greenwood: „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, in: Pedler/van Schendelen [kiadó]: Issues and Cases in European Public Affairs, 1994, 183. és azt követő oldalak, 188. o.) 1984/85‐ig vita tárgyát képezte egy európai gyógyszerár-meghatározási irányelv kidolgozása.
Italian[it]
Secondo Greenwood [Greenwood, «Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying», in Pedler/van Schendelen (a cura di), Issues and Cases in European Public Affairs, 1994, pagg. 183 e segg., pag. 188], fino al 1984/1985 si discuteva dell’elaborazione di una direttiva europea in materia di fissazione dei prezzi dei farmaci.
Lithuanian[lt]
Greenwood „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying“, Pedler, van Schendelen (leid.) Issues and Cases In European Public Affairs, 1994, p. 183 ir paskesni, p. 188) manymu, iki 1984−1985 m. buvo diskutuojama apie Europos direktyvos dėl vaistų kainų nustatymo parengimą.
Latvian[lv]
Greenwood (Greenwood. Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying. Izdevumā: Pedler un van Schendelen [izdevēji]. Issues and Cases In European Public Affairs. 1994, 183. un nākamās lpp., 188. lpp.) norāda, ka līdz 1984. /1985. gadam tika diskutēts par direktīvas izstrādi, ar kuru tiktu noteiktas zāļu cenas Eiropā.
Maltese[mt]
Skont Greenwood [Greenwood, “Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, f’Pedler/van Schendelen (edituri), Issues and Cases in European Public Affairs, 1994, paġni 183 et seq, p. 188], sal-1984/1985 kienet qed tiġi diskussa l-preparazzjoni ta’ direttiva Ewropea dwar l-iffissar tal-prezzijiet tal-prodotti mediċinali.
Dutch[nl]
Volgens Greenwood (Greenwood, „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, in: Pedler/van Schendelen [uitg.], Issues and Cases In European Public Affairs, 1994, blz. 183 e.v., blz. 188) werd tot 1984/1985 overwogen een Europese richtlijn inzake de prijsstelling van geneesmiddelen uit te werken.
Polish[pl]
Według Greenwooda (Greenwood, Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying, w: Pedler/van Schendelen [ed.], Issues and Cases In European Public Affairs, 1994, s. 183 i nast., s. 188) jeszcze na przełomie 1984 i 1985 r. toczyły się dyskusje dotyczące opracowania dyrektywy w sprawie ustalania cen produktów leczniczych.
Portuguese[pt]
Segundo Greenwood (Greenwood, «Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying», in: Pedler/van Schendelen (ed.), Isseus and Cases In European Public Affairs, 1994, pp. 183 e segs. e p. 188), esteve em discussão, até 1984/85, a elaboração de uma directiva europeia relativa à fixação do preço dos medicamentos.
Romanian[ro]
Potrivit Greenwood [Greenwood, „Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, în Pedler/van Schendelen (ed.), Issues and Cases In European Public Affairs, 1994, p. 183 și urm., p. 188], până în 1984/1985 a fost discutată pregătirea unei directive europene privind stabilirea prețurilor medicamentelor.
Slovak[sk]
Podľa GREENWOODA: Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying. In: PEDLER, VAN SCHENDELEN (ed.): Issues and Cases In European Public Affairs. 1994, s. 188, až do roku 1984/1985 sa diskutovalo o príprave európskej smernice týkajúcej sa stanovovania cien liekov.
Slovenian[sl]
Greenwood (Greenwood, Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying, v: Pedler, van Schendelen [ur.], Issues and Cases in European Public Affairs, 1994, str. 183 in naslednje, str. 188) pravi, da se je do let 1984/85 razpravljajo o tem, da bi se pripravila evropska direktiva o določanju cen zdravil.
Swedish[sv]
Enligt Greenwood (Greenwood, ”Pharmaceuticals and Biotechnology; virtues and trends in EU Lobbying”, i Pedler/van Schendelen (utgivare), Issues and Cases in European Public Affairs, 1994, s. 183 och följande sidor, s. 188, diskuterades fram till åren 1984/85 utarbetandet av ett europeiskt direktiv om prissättning på läkemedel.